| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |